Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$14.2M
+26.9% from 2023
Prescriptions
4,431
$3,213.82 per claim
Patients
4,389
2,804 prescribers
Total spending, 2024
$14.2M
$3,244.58 per patient
Medicare prescription drug plans paid $14.2M for Venclexta Starting Pack in 2024, for 4,431 prescriptions and refills to 4,389 patients (up 26.9% from 2023). The average cost per claim was $3,213.82.
California had the highest Medicare cost for Venclexta Starting Pack in 2024: $1.2M for 376 claims, followed by Florida ($1.1M).
Josie Montegaard, nurse practitioner in Boston, MA, had the highest Medicare cost for Venclexta Starting Pack in 2024: 14 claims costing $45K.
Venclexta Starting Pack is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Josie Montegaard Boston, MA | Nurse Practitioner | 14 | 14 | $45K |
| Chang Xia Sylvania, OH | Hematology-Oncology | 11 | Under 11 | $37K |
| Carter T Davis |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,258 | 3,395 | 3,366 | $10.3M |
| 2023 | 2,329 | 3,425 | 3,394 | $11.2M |
| 2024 | 2,804 | 4,431 | 4,389 | $14.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 11 |
| 11 |
| $35K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Abbvie US LLC ABBV | 4,431 | $14.2M |